Accumulation of myeloid-derived suppressor cells in the lungs during Pneumocystis pneumonia

Infection and Immunity

Volumn 80, Issue 10, 2012, Pages 3634-3641

  Zhang, Chen ^a   Lei, Guang Sheng ^a   Shao, Shoujin ^a   Jung, Hsin Wei ^b   Durant, Pamela J ^a   Lee, Chao Hung ^a  

^a INDIANA UNIVERSITY   (United States)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ARGINASE 1; CD11B ANTIGEN; CELL SURFACE MARKER; INDUCIBLE NITRIC OXIDE SYNTHASE; LACTATE DEHYDROGENASE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELL POPULATION; CELL STIMULATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; LUNG; LUNG INJURY; LUNG LAVAGE; LYMPHOCYTE PROLIFERATION; MORPHOLOGY; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PNEUMOCYSTIS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPPRESSOR CELL;

ALBUMINS; ANIMALS; ANTIGENS, CD11B; BRONCHOALVEOLAR LAVAGE FLUID; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; IMMUNITY, CELLULAR; LUNG; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; PNEUMONIA, PNEUMOCYSTIS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES;

EID: 84867593732     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00668-12     Document Type: Article

References (32)

1. Azoulay E, et al. 1999. AIDS-related Pneumocysis carinii pneumonia in the era of adjunctive steroids: implication of BAL neutrophilia. Am. J. Respir. Crit. Care Med. 160:493- 499.
2. Bingisser RM, Tilbrook PA, Holt PG, Kees UR. 1998. Macrophagederived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. J. Immunol. 160:5729 -5734.
3. Bozzette SA, et al. 1990. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocysis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N. Engl. J. Med. 323:1451-1457.
4. Bronte V, Zanovello P. 2005. Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 5:641- 654.
5. Delano MJ, et al. 2007. MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204:1463-1474.
6. Gabrilovich DI, Nagaraj S. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9:162-174.
7. Gagnon S, et al. 1990. Corticosteroids as adjunctive therapy for severe Pneumocysis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial. N. Engl. J. Med. 323: 1444-1450.
8. Gigliotti F, Crow EL, Bhagwat SP, Wright TW. 2006. Sensitized CD8+ T cells fail to control organism burden but accelerate the onset of lung injury during Pneumocysis carinii pneumonia. Infect. Immun. 74:6310- 6316.
9. Gomez-Garcia L, et al. 2005. Intact glycans from cestode antigens are involved in innate activation of myeloid suppressor cells. Parasite Immunol. 27:395-405.
10. Harari O, Liao JK. 2004. Inhibition of MHC II gene transcription by nitric oxide and antioxidants. Curr. Pharm. Des. 10:893- 898.
11. Jia W, Jackson-Cook C, Graf MR. 2010. Tumor-infiltrating, myeloidderived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination model. J. Neuroimmunol. 223: 20-30.
12. Ko HJ, et al. 2007. A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model. Cancer Res. 67:7477-7486.
13. Kusmartsev S, Nagaraj S, Gabrilovich DI. 2005. Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells. J. Immunol. 175:4583- 4592.
14. Lasbury ME, Durant PJ, Bartlett MS, Smith JW, Lee CH. 2003. Correlation of organism burden and alveolar macrophage counts during infec-tion with Pneumocystis carinii and recovery. Clin. Diagn. Lab. Immunol. 10:293-302.
15. Lasbury ME, et al. 2007. Polyamine-mediated apoptosis of alveolar macrophages during Pneumocystis pneumonia. J. Biol. Chem. 282:11009- 11020.
16. Mason GR, Hashimoto CH, Dickman PS, Foutty LF, Cobb CJ. 1989. Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS. Am. Rev. Respir. Dis. 139:1336-1342.
17. Mencacci A, et al. 2002. CD80+Gr-1+myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis. J. Immunol. 169: 3180-3190.
18. Nausch N, Galani IE, Schlecker E, Cerwenka A. 2008. Mononuclear myeloid-derived "suppressor" cells express RAE-1 and activate natural killer cells. Blood 112:4080-4089.
19. Rivoltini L, et al. 2002. Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction. Immunol. Rev. 188:97-113.
20. Rodriguez PC, Ochoa AC. 2008. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol. Rev. 222:180 -191.
21. Rodriguez PC, Quiceno DG, Ochoa AC. 2007. L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood 109:1568 -1573.
22. Rodriguez PC, et al. 2002. Regulation of T cell receptor CD3zeta chain expression by L-arginine. J. Biol. Chem. 277:21123-21129.
23. Sunderkotter C, et al. 2004. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 172: 4410-4417.
24. Suzuki E, Kapoor V, Jassar AS, Kaiser LR, Albelda SM. 2005. Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clin. Cancer Res. 11:6713- 6721.
25. Swain SD, Wright TW, Degel PM, Gigliotti F, Harmsen AG. 2004. Neither neutrophils nor reactive oxygen species contribute to tissue damage during Pneumocystis pneumonia in mice. Infect. Immun. 72:5722- 5732.
26. Terrazas LI, Walsh KL, Piskorska D, McGuire E, Harn DA, Jr. 2001. The schistosome oligosaccharide lacto-N-neotetraose expands Gr1(+) cells that secrete anti-inflammatory cytokines and inhibit proliferation of naive CD4(+) cells: a potential mechanism for immune polarization in helminth infections. J. Immunol. 167:5294 -5303.
27. Van Ginderachter JA, Beschin A, De Baetselier P, Raes G. 2010. Myeloid-derived suppressor cells in parasitic infections. Eur. J. Immunol. 40:2976-2985.
28. Vassallo R, Standing JE, Limper AH. 2000. Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses. J. Immunol. 164:3755-3763.
29. Voisin MB, Buzoni-Gatel D, Bout D, Velge-Roussel F. 2004. Both expansion of regulatory GR1+ CD11b+ myeloid cells and anergy of T lymphocytes participate in hyporesponsiveness of the lung-associated immune system during acute toxoplasmosis. Infect. Immun. 72:5487-5492.
30. Wang SH, et al. 2008. Decreased inflammatory response in Toll-like receptor 2 knockout mice is associated with exacerbated Pneumocysis pneumonia. Microbes Infect. 10:334 -341.
31. Wu L, Du H, Li Y, Qu P, Yan C. 2011. Signal transducer and activator of transcription 3 (Stat3C) promotes myeloid-derived suppressor cell expansion and immune suppression during lung tumorigenesis. Am. J. Pathol. 179:2131-2141.
32. Zhang C, et al. 2006. Toll-like receptor 2 mediates alveolar macrophage response to Pneumocystis murina. Infect. Immun. 74:1857-1864.